APA (7th ed.) Citation

Zhu, Q., Hao, H., Gao, Y., Li, N., Liu, Z., Shu, L., . . . Zhang, L. Dapagliflozin ameliorates kidney injury following limb ischemia-reperfusion via the AMPK/SIRT1/NLRP3 pathway. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Zhu, Qiuxiao, Huiyao Hao, Ya Gao, Na Li, Zibo Liu, Linyi Shu, Qian Wang, and Lihui Zhang. Dapagliflozin Ameliorates Kidney Injury Following Limb Ischemia-reperfusion via the AMPK/SIRT1/NLRP3 Pathway. Taylor & Francis Group.

MLA (9th ed.) Citation

Zhu, Qiuxiao, et al. Dapagliflozin Ameliorates Kidney Injury Following Limb Ischemia-reperfusion via the AMPK/SIRT1/NLRP3 Pathway. Taylor & Francis Group.